On Tuesday, Viking Therapeutics Inc (NASDAQ: VKTX) was 7.49% up from the session before settling in for the closing price of $37.77. A 52-week range for VKTX has been $18.92 – $68.87.
Annual sales at Healthcare sector company slipped by -23.00% over the past five years. When this article was written, the company’s average yearly earnings per share was at -168.51%. With a float of $109.62 million, this company’s outstanding shares have now reached $112.45 million.
Viking Therapeutics Inc (VKTX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Viking Therapeutics Inc stocks. The insider ownership of Viking Therapeutics Inc is 3.02%, while institutional ownership is 66.47%. The most recent insider transaction that took place on Oct 28 ’25, was worth 216,492. In this transaction Chief Operating Officer of this company sold 6,185 shares at a rate of $35.00, taking the stock ownership to the 382,467 shares. Before that another transaction happened on Oct 27 ’25, when Company’s Director sold 60,000 for $35.57, making the entire transaction worth $2,134,278. This insider now owns 30,000 shares in total.
Viking Therapeutics Inc (VKTX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.32 earnings per share (EPS) during the time that was less than consensus figure (set at -0.27) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.94 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -168.51% per share during the next fiscal year.
Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators
You can see what Viking Therapeutics Inc (VKTX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 28.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.12, a number that is poised to hit -0.89 in the next quarter and is forecasted to reach -3.70 in one year’s time.
Technical Analysis of Viking Therapeutics Inc (VKTX)
Viking Therapeutics Inc (NASDAQ: VKTX) saw its 5-day average volume 4.65 million, a negative change from its year-to-date volume of 4.84 million. As of the previous 9 days, the stock’s Stochastic %D was 71.25%.
During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 91.54%, which indicates a significant decrease from 98.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.58 in the past 14 days, which was higher than the 1.87 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.78, while its 200-day Moving Average is $29.38. Nevertheless, the first resistance level for the watch stands at $41.84 in the near term. At $43.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $45.47. If the price goes on to break the first support level at $38.21, it is likely to go to the next support level at $35.82. Assuming the price breaks the second support level, the third support level stands at $34.58.
Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats
There are 113,036K outstanding shares of the company, which has a market capitalization of 4.59 billion. As of now, sales total 0 K while income totals -109,960 K. Its latest quarter income was 0 K while its last quarter net income were -90,790 K.
